What C-Suites and Boards Neglect About Their Companies’ IP
The question is not solely what your catalog is worth today — it is how long you, or someone else, will control it.
Private equity has identified music catalogs as long-term, yield-generating assets. Streaming, synchronization, and global licensing have transformed songs into predictable revenue streams. Billions of dollars have flowed into catalog acquisitions. But the structure of these deals is evolving as the legal and technological landscape changes.
The Board's Duty of Care
Under U.S. corporate law, especially Delaware law (which governs most public companies), directors owe the company fiduciary duties of care, loyalty, and good-faith oversight.
In In re Caremark International Inc. Derivative Litigation, the courts made clear that boards need real oversight systems to monitor the company's key risks. For many companies today, IP protection and monetization are exactly that: core risks and opportunities. Ignore them, and directors can end up exposed to oversight liability.
The Strategic Blind Spots
1. IP is a mission-critical asset now
Companies chronically undervalue their own IP because accounting rules treat a lot of internally generated IP as an expense instead of an asset on the balance sheet. Boards that skip independent IP valuation may be misreading what the company is actually worth.
For a lot of companies right now:
IP makes up the majority of enterprise value
AI systems are actively learning from proprietary data
Competitors are using technology to replicate or sidestep traditional IP protections
Ignore these dynamics and you risk losing competitive advantage, watching licensing markets erode, and seeing asset value shrink. Overseeing how the C-suite manages IP is squarely a board-level job.
2. Three failures that keep showing up
Failing to value IP as an asset class. Accounting rules tend to hide the real value of internally developed IP, so boards relying only on financial statements can end up with an incomplete picture of enterprise value. Independent IP valuation and portfolio analysis are increasingly necessary for capital allocation, M&A, and licensing decisions.
Failing to monetize what's already there. Plenty of companies are sitting on underused IP: legacy content libraries, dormant patents, proprietary datasets, brand extensions nobody's pursued. In a market where licensing opportunities keep expanding, especially around AI, leaving that IP on the shelf isn't neutral. It's actively destroying value.
Failing to protect against cyber and AI risk. Generative AI models are training on huge volumes of corporate data and content. Current legal trends suggest some AI training might qualify as fair use in limited situations, but lawful sourcing and market harm are the deciding factors, and the more licensing markets exist, the stronger rights holders' claims become. Boards that don't have data governance policies, licensing frameworks, and technical protections in place risk letting their own IP get used in ways that quietly undercut its long-term value.
What Real Board Oversight Requires Now
IP oversight can't be a once-a-year exercise. It needs to be ongoing.
Boards should be requiring:
Regular IP portfolio audits
IP built into enterprise risk management, not siloed from it
Clear strategies for AI licensing and data use
IP strategy aligned with M&A, product, and technology decisions
The Strategic Reality
The legal standards for a board's fiduciary duties haven't changed. The world they're being applied to has.
Boards that fail to treat intellectual property as a mission-critical asset are not simply missing opportunities. They may be failing to meet their oversight obligations in a new reality -- every business is now a data business, which means IP is important to every business.
